97 related articles for article (PubMed ID: 1799355)
41. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial.
Smith S; Rinehart JS; Ruddock VE; Schiff I
Obstet Gynecol; 1987 Jul; 70(1):37-43. PubMed ID: 3299178
[TBL] [Abstract][Full Text] [Related]
42. Bromocriptine and norethisterone in the treatment of premenstrual syndrome.
Ylöstalo P; Kauppila A; Puolakka J; Rönnberg L; Jänne O
Obstet Gynecol; 1982 Mar; 59(3):292-8. PubMed ID: 6804900
[TBL] [Abstract][Full Text] [Related]
43. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
Watanabe H; Lau DC; Guyn HL; Wong NL
Clin Invest Med; 1997 Aug; 20(4):211-23. PubMed ID: 9258576
[TBL] [Abstract][Full Text] [Related]
44. Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study.
Higuchi T; Ueno T; Uchiyama S; Matsuki S; Ogawa M; Takamatsu K
BMC Complement Med Ther; 2023 Apr; 23(1):136. PubMed ID: 37118716
[TBL] [Abstract][Full Text] [Related]
45. Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures.
Vujović S; Zidverc J; Stojanović M; Penezić Z; Ivović M; Dukić V; Drezgić M
Gynecol Endocrinol; 2005 Nov; 21(5):243-7. PubMed ID: 16373242
[TBL] [Abstract][Full Text] [Related]
46. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
[TBL] [Abstract][Full Text] [Related]
47. Isolating with physical restraint low status female monkeys during luteal phase might make an appropriate premenstrual depression syndrome model.
Qiao M; Zhao Q; Zhang H; Wang H; Xue L; Wei S
J Affect Disord; 2007 Sep; 102(1-3):81-91. PubMed ID: 17258814
[TBL] [Abstract][Full Text] [Related]
48. Prolactin suppression in the treatment of premenstrual syndrome.
Graham JJ; Harding PE; Wise PH; Berriman H
Med J Aust; 1978 Nov; 2(3 Suppl):18-20. PubMed ID: 370525
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome.
London RS; Murphy L; Kitlowski KE; Reynolds MA
J Reprod Med; 1987 Jun; 32(6):400-4. PubMed ID: 3302248
[TBL] [Abstract][Full Text] [Related]
50. Premenstrual syndrome.
Wyatt K
Clin Evid; 2002 Jun; (7):1739-57. PubMed ID: 12230785
[No Abstract] [Full Text] [Related]
51. Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome.
Taskin O; Gökdeniz R; Yalcinoglu A; Buhur A; Burak F; Atmaca R; Ozekici U
Hum Reprod; 1998 Sep; 13(9):2402-5. PubMed ID: 9806257
[TBL] [Abstract][Full Text] [Related]
52. Possible new relief for premenstrual syndrome.
Simmons MK
JAMA; 1983 Sep; 250(11):1371, 1375. PubMed ID: 6684187
[No Abstract] [Full Text] [Related]
53. Effect of spironolactone on premenstrual syndrome symptoms.
Vellacott ID; O'Brien PM
J Reprod Med; 1987 Jun; 32(6):429-34. PubMed ID: 3302250
[TBL] [Abstract][Full Text] [Related]
54. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
[TBL] [Abstract][Full Text] [Related]
55. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Freeman EW; Sondheimer SJ; Rickels K
Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
[TBL] [Abstract][Full Text] [Related]
56. Effect of Royal Jelly on premenstrual syndrome among Iranian medical sciences students: a randomized, triple-blind, placebo-controlled study.
Taavoni S; Barkhordari F; Goushegir A; Haghani H
Complement Ther Med; 2014 Aug; 22(4):601-6. PubMed ID: 25146061
[TBL] [Abstract][Full Text] [Related]
57. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
[TBL] [Abstract][Full Text] [Related]
58. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
[TBL] [Abstract][Full Text] [Related]
59. Cortisol awakening response is blunted and pain perception is increased during menses in cyclic women.
Ozgocer T; Ucar C; Yildiz S
Psychoneuroendocrinology; 2017 Mar; 77():158-164. PubMed ID: 28064085
[TBL] [Abstract][Full Text] [Related]
60. Plasma progesterone, oestradiol 17 beta and premenstrual symptoms.
Taylor JW
Acta Psychiatr Scand; 1979 Jul; 60(1):76-86. PubMed ID: 573048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
